Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 965

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Matricellular proteins: extracellular modulators of cell function

Bornstein, Paul, Sage, E.Helene·2002·Current Opinion in Cell Biology
DOI 10.1016/s0955-0674(02)00361-7
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0955-0674(02)00361-7

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 64

  1. Carragher, 1999, Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin, J Cell Biol, 147, 619, 10.1083/jcb.147.3.619 · DOI
  2. Bornstein, 1995, Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1, J Cell Biol, 130, 503, 10.1083/jcb.130.3.503 · DOI · Paper page
  3. Bornstein, 2001, Thrombospondins as matricellular modulators of cell function, J Clin Invest, 107, 929, 10.1172/JCI12749 · DOI
  4. Sage, 1991, Minireview: extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin, J Biol Chem, 266, 14831, 10.1016/S0021-9258(18)98545-5 · DOI
  5. Lau, 1999, The CCN family of angiogenic regulators: the integrin connection, Exp Cell Res, 248, 44, 10.1006/excr.1999.4456 · DOI
  6. Bornstein, 2000, Thrombospondin 2, a matricellular protein with diverse functions, Matrix Biol, 19, 557, 10.1016/S0945-053X(00)00104-9 · DOI
  7. Brekken, 2000, SPARC, a matricellular protein: at the crossroads of cell-matrix communication, Matrix Biol, 19, 816, 10.1016/S0945-053X(00)00105-0 · DOI
  8. Rittling, 1999, Osteopontin function in pathology: lessons from osteopontin-deficient mice, Exp Nephrol, 7, 103, 10.1159/000020591 · DOI
  9. Giachelli, 2000, Osteopontin: a versatile regulator of inflammation and biomineralization, Matrix Biol, 19, 615, 10.1016/S0945-053X(00)00108-6 · DOI
  10. Jones, 2000, Tenascin-C in development and disease: gene regulation and cell function, Matrix Biol, 19, 581, 10.1016/S0945-053X(00)00106-2 · DOI
  11. Adams, 2001, Thrombospondins: multifunctional regulators of cell interactions, Annu Rev Cell Dev Biol, 17, 25, 10.1146/annurev.cellbio.17.1.25 · DOI
  12. Chen, 2000, The cell biology of thrombospondin-1, Matrix Biol, 19, 597, 10.1016/S0945-053X(00)00107-4 · DOI
  13. Lawler, 2000, The functions of thrombospondin-1 and –2, Curr Opin Cell Biol, 12, 634, 10.1016/S0955-0674(00)00143-5 · DOI
  14. Murphy-Ullrich, 2001, The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?, J Clin Invest, 107, 785, 10.1172/JCI12609 · DOI
  15. Goicoechea, 2000, Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin, J Biol Chem, 275, 36358, 10.1074/jbc.M005951200 · DOI
  16. Hohenester, 1997, Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40, EMBO J, 16, 3778, 10.1093/emboj/16.13.3778 · DOI
  17. Huang, 2001, Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation, Cancer Res, 61, 8586
  18. Yang, 2000, Matricellular proteins as modulators of cell-matrix interactions: the adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2, Mol Biol Cell, 11, 3353, 10.1091/mbc.11.10.3353 · DOI
  19. Yang, 2001, Extracellular MMP2 levels are regulated by the LRP scavenger receptor and thrombospondin 2, J Biol Chem, 276, 8403, 10.1074/jbc.M008925200 · DOI
  20. Agah A, Kyriakides TR, Lawler J, Bornstein P: The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double TSP1/TSP2-null mice. Am J Pathol 2002, in press. This paper demonstrates that the functions of thrombospondin 1 (TSP1) and TSP2 in vivo reflect their spatial and temporal expression, and emphasizes the need to study matricellular proteins in the context of the whole organism. · DOI
  21. Kyriakides, 2001, Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of TSP2-null mice, Am J Pathol, 159, 1255, 10.1016/S0002-9440(10)62512-6 · DOI
  22. Pepper, 2001, Extracellular proteolysis and angiogenesis, Thromb Haemost, 86, 346, 10.1055/s-0037-1616232 · DOI
  23. Mansfield, 1994, Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes, J Immunol, 153, 4219, 10.4049/jimmunol.153.9.4219 · DOI
  24. Huynh, 1999, A calcium-binding motif in SPARC/osteonectin inhibits chordomesoderm cell migration during Xenopus gastrulation: evidence of counteradhesive activity in vivo, Dev Growth Differ, 41, 407, 10.1046/j.1440-169x.1999.00443.x · DOI
  25. Bradshaw, 2001, SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury, J Clin Invest, 107, 1049, 10.1172/JCI12939 · DOI
  26. Rempel, 2001, SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins, J Neurooncol, 53, 149, 10.1023/A:1012201300188 · DOI
  27. Bradshaw, 2002, SPARC-null mice exhibit accelerated cutaneous wound closure, J Histochem Cytochem, 50, 1, 10.1177/002215540205000101 · DOI
  28. Bradshaw, 2002, SPARC-null mice display enhanced fibrovascular invasion of subcutaneous sponge implants, Wound Repair Regen, 9, 522, 10.1046/j.1524-475x.2001.00522.x · DOI
  29. Danen, 2001, Fibronectin, integrins, and growth control, J Cell Physiol, 189, 1, 10.1002/jcp.1137 · DOI
  30. Cheresh, 2002, Integrin-mediated death: an explanation of the integrin-knockout phenotype?, Nat Med, 8, 193, 10.1038/nm0302-193 · DOI
  31. Kyriakides, 1998, Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis, J Cell Biol, 140, 419, 10.1083/jcb.140.2.419 · DOI
  32. Bornstein, 2000, Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis, J Invest Dermatol Symp Proc, 5, 61, 10.1046/j.1087-0024.2000.00005.x · DOI
  33. Delany, 2000, Osteopenia and decreased bone formation in osteonectin-deficient mice, J Clin Invest, 105, 915, 10.1172/JCI7039 · DOI
  34. Francki, 1999, SPARC regulates the expression of collagen type I and TGF-β1 in mesangial cells, J Biol Chem, 274, 32145, 10.1074/jbc.274.45.32145 · DOI
  35. Yan, 2002, Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice, J Cell Sci, 115, 2747, 10.1242/jcs.115.13.2747 · DOI
  36. Schwartz, 2001, Integrin signaling revisited, Trends Cell Biol, 11, 466, 10.1016/S0962-8924(01)02152-3 · DOI
  37. Bradshaw, 1999, Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and proliferation rates relative to wild-type cells, Mol Biol Cell, 10, 1569, 10.1091/mbc.10.5.1569 · DOI
  38. Motamed, 2002, Interaction of SPARC with human vascular smooth muscle cells: abrogation of mitogen-stimulated proliferation, J Cell Biochem, 84, 759, 10.1002/jcb.10095 · DOI
  39. Yiu, 2001, SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells, Am J Pathol, 159, 609, 10.1016/S0002-9440(10)61732-4 · DOI
  40. Denhardt, 2001, Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival, J Clin Invest, 107, 1055, 10.1172/JCI12980 · DOI
  41. Lin, 2001, The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway, J Biol Chem, 276, 46024, 10.1074/jbc.M105132200 · DOI
  42. Rodriguez-Manzaneque, 2001, Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor, Proc Natl Acad Sci USA, 98, 12485, 10.1073/pnas.171460498 · DOI
  43. Jimenez, 2000, Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1, Nat Med, 6, 41, 10.1038/71517 · DOI · Paper page
  44. Jimenez, 2001, c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1, Oncogene, 20, 3443, 10.1038/sj.onc.1204464 · DOI
  45. Volpert, 2002, Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor, Nat Med, 8, 349, 10.1038/nm0402-349 · DOI
  46. Armstrong, 2002, Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism, Mol Biol Cell, 13, 1893, 10.1091/mbc.E01-09-0066. · DOI
  47. Wakefield, 2002, TGF-β signaling: positive and negative effects on tumorigenesis, Curr Opin Genet Dev, 12, 22, 10.1016/S0959-437X(01)00259-3 · DOI
  48. Murphy-Ullrich, 2000, Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology, Cytokine Growth Factor Rev, 11, 59, 10.1016/S1359-6101(99)00029-5 · DOI
  49. Crawford, 1998, Thrombospondin-1 is a major activator of TGF-β1 in vivo, Cell, 93, 1159, 10.1016/S0092-8674(00)81460-9 · DOI
  50. Miao, 2001, Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms, Cancer Res, 61, 7830
  51. Abelouahed, 2000, Activation of platelet-transforming growth factor β-1 in the absence of thrombospondin-1, J Biol Chem, 275, 17933, 10.1074/jbc.275.24.17933 · DOI
  52. Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7 · DOI · Paper page
  53. Hogg, 1994, Thrombospondin 1 as an enzyme inhibitor, Thromb Haemost, 72, 787, 10.1055/s-0038-1648962 · DOI
  54. Streit, 1999, Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis, Proc Natl Acad Sci USA, 96, 14888, 10.1073/pnas.96.26.14888 · DOI
  55. Hawighorst, 2001, Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism, EMBO J, 20, 2631, 10.1093/emboj/20.11.2631 · DOI
  56. Taraboletti, 2000, The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells, FASEB J, 14, 1674, 10.1096/fj.99-0931fje · DOI
  57. Chandrasekaran, 2000, Cell contact-dependent activation of α3β1 integrin modulates endothelial cell responses to thrombospondin-1, Mol Biol Cell, 11, 2885, 10.1091/mbc.11.9.2885 · DOI
  58. Sage, 1997, Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis, Trends Cell Biol, 7, 182, 10.1016/S0962-8924(97)01037-4 · DOI
  59. Agnihotri, 2001, Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin), J Biol Chem, 276, 28261, 10.1074/jbc.M103608200 · DOI
  60. Marneros, 2001, The role of collagen-derived proteolytic fragments in angiogenesis, Matrix Biol, 20, 337, 10.1016/S0945-053X(01)00151-2 · DOI
  61. Inoki, 2001, Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis, FASEB J, 15, U393
  62. Lawler, 1998, Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia, J Clin Invest, 101, 982, 10.1172/JCI1684 · DOI
  63. Yoshitake, 1999, Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption, Proc Natl Acad Sci USA, 96, 8156, 10.1073/pnas.96.14.8156 · DOI
  64. Mackie, 1999, The tenascin-C knockout revisited, J Cell Sci, 112, 3847, 10.1242/jcs.112.22.3847 · DOI

Cited by

See all 965

Metadata

Authors
Bornstein, P., & Sage, E. H.
Venue
Current Opinion in Cell Biology
Publisher
Elsevier BV
Published
2002-10
Volume
14
Issue
5
Pages
608-616
ISSN
0955-0674 (ISSN-L)
DOI
10.1016/s0955-0674(02)00361-7
OpenAlex
W2083544543
Cited by
965
References
5
FWCI
1.61
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.